Opsoclonus-myoclonus syndrome: Clinical characteristics, therapeutic considerations, and prognostic factors in a Spanish paediatric cohort V. Cantarín-Extremera; M. Jiménez-Legido; S. Aguilera-Albesa; A. Hedrera-Fernández; L. Arrabal-Fernández; N. Gorría-Redondo; I. Martí-Carrera; M.E. Yoldi-Pedtri; M. Sagaseta-De Ilúrdoz; L. González-Gutiérrez-Solana;

Immune-mediated necrotising myopathy after treatment with adalimumab in a patient with HLA-B27 ankylosing spondylitis A. Chavarría-Miranda; A. Hernández Lain; O. Toldos González; M.I. Pedraza Hueso;

Paraneoplastic opsoclonus-myoclonus syndrome in a patient with oesophageal adenocarcinoma J.A. Del Valle Pérez; I. Redondo Peñas; A. Layos Romero; T. Segura;